C

Celosia Therapeutics

Celosia Therapeutics is a biotechnology company focused on developing treatments for Motor Neuron Disease (MND). The company aims to address significant unmet medical needs in this area, making it a notable player in the biotech sector. The recent funding will support their commercialization efforts.

Total raised
Undisclosed
tracked to date
Latest round
Grant
Nov 18, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Australia.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 Australia Funding Report

Read the Q4 2026 Australia report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-australia-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 Australia Funding Report</a>

Funding history

  1. 1
    $2 millionGrantNov 18, 2026
    Announcement ↗

Celosia Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile